Abstract
Canada is a wealthy nation with a geographically diverse population, seeking health innovations to better serve patients in accordance with the Canada Health Act. In this country, population and geography converge with social determinants, policy, procurement regulations, and technological advances with the goal to achieve equity in the management and distribution of health care. Rural and remote patients are a vulnerable population; when managing chronic conditions like cardiovascular disease, there is currently inequity to accessing specialist physicians at the recommended frequency—increasing the likelihood of poor health outcomes. Ensuring equitable care for this population is an unrealized priority of several provincial and federal government mandates. Virtual care technology might provide practical, economical, and innovative solutions to remedy this discrepancy. We conducted a scoping review of the literature pertaining to the use of virtual care technologies to monitor patients living in rural areas of Canada with cardiovascular disease. A search strategy was developed to identify the literature specific to this context across 3 bibliographic databases. Two hundred thirty-two unique citations were ultimately assessed for eligibility, of which 37 met the inclusion criteria. In our assessment of these articles, we provide a summary of the interventions studied, their reported effectiveness in reducing adverse events and mortality, the challenges to implementation, and the receptivity of these technologies among patients, providers, and policy-makers. Furthermore, we glean insight into the barriers and opportunities to ensure equitable care for rural patients and conclude that there is an ongoing need for clinical trials on virtual care technologies in this context.
Original language | English |
---|---|
Pages (from-to) | 133-147 |
Number of pages | 15 |
Journal | CJC Open |
Volume | 4 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2022 |
Bibliographical note
Funding Information:The authors acknowledge the help of Jackie Phinney (Librarian, W.K. Kellogg Health Sciences Library, Dalhousie University) who assisted in the development of the literature search strategy. This work was generously supported by AGE-WELL NCE, Inc, a member of the Networks of Centres of Excellence program, the New Brunswick Health Research Foundation and the New Brunswick Innovation Foundation. Neither of these organizations played a role in the design, data collection, analysis, or interpretation of this literature review, or in the preparation of the report. K.R.B. has a direct financial interest in medical technology innovation companies as a director or shareholder of NBBM, Inc, and Routinify, Inc; has received partnership grant/contract funding or financial in-kind support from or serves as a medical science advisor to Ausculsciences, Inc, BaioTeq, Inc, Cloud DX Inc, eVisitNB (Maple Inc), Medtronic Canada Inc, Servier Canada, Inc, IBM Canada, and the Government of New Brunswick. H.C. has a direct financial interest in medical technology innovation companies as a director or shareholder of eVisitNB (Maple, Inc). J.-F.L. and S.L. have received medical technology innovation partnership grant/contract funding or financial in-kind support from Medtronic, Inc, and Servier Canada Inc. The remaining authors have no conflicts of interest to disclose. None of these enterprises listed in this section played a role in the design, data collection, analysis, or interpretation of this literature review, or in the preparation of the report.
Funding Information:
K.R.B. has a direct financial interest in medical technology innovation companies as a director or shareholder of NBBM, Inc, and Routinify, Inc; has received partnership grant/contract funding or financial in-kind support from or serves as a medical science advisor to Ausculsciences, Inc, BaioTeq, Inc, Cloud DX Inc, eVisitNB (Maple Inc), Medtronic Canada Inc, Servier Canada, Inc, IBM Canada, and the Government of New Brunswick. H.C. has a direct financial interest in medical technology innovation companies as a director or shareholder of eVisitNB (Maple, Inc). J.-F.L. and S.L. have received medical technology innovation partnership grant/contract funding or financial in-kind support from Medtronic, Inc, and Servier Canada Inc. The remaining authors have no conflicts of interest to disclose. None of these enterprises listed in this section played a role in the design, data collection, analysis, or interpretation of this literature review, or in the preparation of the report.
Funding Information:
This work was generously supported by AGE-WELL NCE, Inc, a member of the Networks of Centres of Excellence program, the New Brunswick Health Research Foundation and the New Brunswick Innovation Foundation. Neither of these organizations played a role in the design, data collection, analysis, or interpretation of this literature review, or in the preparation of the report.
Publisher Copyright:
© 2021 The Authors
ASJC Scopus Subject Areas
- Cardiology and Cardiovascular Medicine
PubMed: MeSH publication types
- Journal Article
- Review